KPTI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Karyopharm Therapeutics Inc (KPTI).


$84.75M Market Cap.

As of 02/19/2025 5:00 PM ET (MRY) • Disclaimer

KPTI Market Cap. (MRY)


KPTI Shares Outstanding (MRY)


KPTI Assets (MRY)


Total Assets

$164.42M

Total Liabilities

$350.44M

Total Investments

$46.24M

KPTI Income (MRY)


Revenue

$145.24M

Net Income

-$76.42M

Operating Expense

$258.67M

KPTI Cash Flow (MRY)


CF Operations

-$127.49M

CF Investing

$95.47M

CF Financing

$41.65M

KPTI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

KPTI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$164,418,000 (-31.62%)

$240,438,000 (-32.87%)

$358,172,000 (17.32%)

$305,305,000 (-2.47%)

Assets Current

$156,492,000 (-33.10%)

$233,921,000 (-33.20%)

$350,162,000 (27.05%)

$275,606,000 (-0.33%)

Assets Non-Current

$7,926,000 (21.62%)

$6,517,000 (-18.64%)

$8,010,000 (-73.03%)

$29,699,000 (-18.68%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$186,017,000 (-36.57%)

-$136,206,000 (-717.76%)

-$16,656,000 (79.09%)

-$79,673,000 (-257.62%)

Property Plant & Equipment Net

$6,284,000 (28.72%)

$4,882,000 (-33.82%)

$7,377,000 (-22.81%)

$9,557,000 (-17.48%)

Cash & Equivalents

$62,814,000 (18.09%)

$53,192,000 (-61.14%)

$136,885,000 (-30.67%)

$197,445,000 (121.55%)

Accumulated Other Comprehensive Income

-$356,000 (-121.12%)

-$161,000 (74.76%)

-$638,000 (-434.03%)

$191,000 (-63.13%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$46,236,000 (-66.79%)

$139,212,000 (-2.50%)

$142,779,000 (274.20%)

$38,156,000 (-79.65%)

Investments Current

$46,236,000 (-66.79%)

$139,212,000 (-2.50%)

$142,779,000 (274.20%)

$38,156,000 (-76.64%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$4,739,000 (55.73%)

$3,043,000 (-27.96%)

$4,224,000 (2.87%)

$4,106,000 (55.30%)

Trade & Non-Trade Receivables

$30,766,000 (14.11%)

$26,962,000 (-42.74%)

$47,086,000 (109.30%)

$22,497,000 (74.65%)

Trade & Non-Trade Payables

$5,107,000 (63.53%)

$3,123,000 (12.62%)

$2,773,000 (72.99%)

$1,603,000 (-63.98%)

Accumulated Retained Earnings (Deficit)

-$1,563,460,000 (-5.14%)

-$1,487,038,000 (-10.65%)

-$1,343,939,000 (-14.02%)

-$1,178,648,000 (-10.19%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$194,524,000 (9.89%)

$177,016,000 (-1.15%)

$179,074,000 (-0.83%)

$180,578,000 (37.71%)

Debt Current

$24,864,000 (651.63%)

$3,308,000 (15.18%)

$2,872,000 (24.01%)

$2,316,000 (20.81%)

Debt Non-Current

$169,660,000 (-2.33%)

$173,708,000 (-1.42%)

$176,202,000 (-1.16%)

$178,262,000 (37.96%)

Total Liabilities

$350,435,000 (-6.96%)

$376,644,000 (0.48%)

$374,828,000 (-2.64%)

$384,978,000 (46.66%)

Liabilities Current

$92,264,000 (32.79%)

$69,479,000 (5.42%)

$65,908,000 (-10.59%)

$73,718,000 (22.45%)

Liabilities Non-Current

$258,171,000 (-15.95%)

$307,165,000 (-0.57%)

$308,920,000 (-0.75%)

$311,260,000 (53.86%)

KPTI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$145,237,000 (-0.55%)

$146,033,000 (-7.03%)

$157,074,000 (-25.14%)

$209,819,000 (94.12%)

Cost of Revenue

$6,007,000 (21.55%)

$4,942,000 (-5.20%)

$5,213,000 (53.23%)

$3,402,000 (25.77%)

Selling General & Administrative Expense

$115,441,000 (-12.47%)

$131,881,000 (-9.30%)

$145,401,000 (1.08%)

$143,846,000 (13.79%)

Research & Development Expense

$143,232,000 (3.23%)

$138,750,000 (-6.67%)

$148,662,000 (-7.57%)

$160,842,000 (6.65%)

Operating Expenses

$258,673,000 (-4.42%)

$270,631,000 (-7.97%)

$294,063,000 (-3.49%)

$304,688,000 (9.90%)

Interest Expense

$37,422,000 (57.08%)

$23,823,000 (-4.69%)

$24,996,000 (-4.03%)

$26,046,000 (-4.03%)

Income Tax Expense

$57,000 (-82.35%)

$323,000 (-12.47%)

$369,000 (37.69%)

$268,000 (-13.27%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$76,422,000 (46.60%)

-$143,099,000 (13.43%)

-$165,291,000 (-33.20%)

-$124,088,000 (36.78%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$76,422,000 (46.60%)

-$143,099,000 (13.43%)

-$165,291,000 (-33.20%)

-$124,088,000 (36.78%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$76,422,000 (46.60%)

-$143,099,000 (13.43%)

-$165,291,000 (-33.20%)

-$124,088,000 (36.78%)

Weighted Average Shares

$121,863,000 (6.69%)

$114,221,000 (39.51%)

$81,871,000 (8.84%)

$75,218,000 (4.41%)

Weighted Average Shares Diluted

$126,809,000 (11.02%)

$114,221,000 (39.51%)

$81,871,000 (8.84%)

$75,218,000 (4.41%)

Earning Before Interest & Taxes (EBIT)

-$38,943,000 (67.26%)

-$118,953,000 (14.99%)

-$139,926,000 (-43.11%)

-$97,774,000 (42.09%)

Gross Profit

$139,230,000 (-1.32%)

$141,091,000 (-7.09%)

$151,861,000 (-26.43%)

$206,417,000 (95.88%)

Operating Income

-$119,443,000 (7.79%)

-$129,540,000 (8.90%)

-$142,202,000 (-44.70%)

-$98,271,000 (42.82%)

KPTI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$95,473,000 (1102.43%)

$7,940,000 (107.62%)

-$104,256,000 (-173.50%)

$141,840,000 (364.21%)

Net Cash Flow from Financing

$41,646,000 (3605.16%)

$1,124,000 (-99.42%)

$193,738,000 (163.06%)

$73,648,000 (-57.20%)

Net Cash Flow from Operations

-$127,486,000 (-37.49%)

-$92,723,000 (38.00%)

-$149,554,000 (-39.62%)

-$107,116,000 (33.15%)

Net Cash Flow / Change in Cash & Cash Equivalents

$9,622,000 (111.50%)

-$83,693,000 (-38.20%)

-$60,560,000 (-155.91%)

$108,324,000 (360.59%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$95,615,000 (1104.22%)

$7,940,000 (107.62%)

-$104,138,000 (-170.58%)

$147,552,000 (375.59%)

Capital Expenditure

-$142,000 (0%)

$0 (0%)

-$118,000 (44.34%)

-$212,000 (-46.21%)

Issuance (Repayment) of Debt Securities

$80,712,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$1,452,000 (29.18%)

$1,124,000 (-99.42%)

$193,738,000 (1319.53%)

$13,648,000 (-92.07%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$11,000 (67.65%)

-$34,000 (93.03%)

-$488,000 (-916.67%)

-$48,000 (-117.91%)

Share Based Compensation

$18,426,000 (-15.12%)

$21,709,000 (-38.67%)

$35,399,000 (18.86%)

$29,783,000 (22.03%)

Depreciation Amortization & Accretion

$340,000 (-35.85%)

$530,000 (-14.65%)

$621,000 (-21.29%)

$789,000 (-18.83%)

KPTI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

95.90% (-0.72%)

96.60% (-0.10%)

96.70% (-1.73%)

98.40% (0.92%)

Profit Margin

-52.60% (46.33%)

-98.00% (6.84%)

-105.20% (-78.00%)

-59.10% (67.46%)

EBITDA Margin

-26.60% (67.20%)

-81.10% (8.57%)

-88.70% (-91.99%)

-46.20% (70.25%)

Return on Average Equity (ROAE)

47.30% (-70.82%)

162.10% (-12.61%)

185.50% (22.77%)

151.10% (182.79%)

Return on Average Assets (ROAA)

-39.60% (21.58%)

-50.50% (12.93%)

-58.00% (-30.93%)

-44.30% (18.42%)

Return on Sales (ROS)

-26.80% (67.12%)

-81.50% (8.53%)

-89.10% (-91.20%)

-46.60% (70.17%)

Return on Invested Capital (ROIC)

-15.50% (56.70%)

-35.80% (26.19%)

-48.50% (-25.32%)

-38.70% (27.53%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.07 (-55.06%)

-0.69 (58.88%)

-1.68 (56.81%)

-3.9 (31.52%)

Price to Sales Ratio (P/S)

0.57 (-16.25%)

0.68 (-61.79%)

1.77 (-23.12%)

2.31 (-77.66%)

Price to Book Ratio (P/B)

-0.46 (37.28%)

-0.73 (95.61%)

-16.57 (-171.71%)

-6.1 (-127.05%)

Debt to Equity Ratio (D/E)

-1.88 (31.86%)

-2.77 (87.71%)

-22.5 (-365.73%)

-4.83 (-193.05%)

Earnings Per Share (EPS)

-0.63 (49.60%)

-1.25 (38.12%)

-2.02 (-22.42%)

-1.65 (39.34%)

Sales Per Share (SPS)

1.19 (-6.80%)

1.28 (-33.35%)

1.92 (-31.19%)

2.79 (85.93%)

Free Cash Flow Per Share (FCFPS)

-1.05 (-28.94%)

-0.81 (55.58%)

-1.83 (-28.10%)

-1.43 (35.89%)

Book Value Per Share (BVPS)

-1.53 (-28.02%)

-1.19 (-487.19%)

-0.2 (80.83%)

-1.06 (-250.85%)

Tangible Assets Book Value Per Share (TABVPS)

1.35 (-35.91%)

2.1 (-51.89%)

4.38 (7.79%)

4.06 (-6.58%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (33.33%)

-3 (40.00%)

-5 (28.57%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.33 (-172.04%)

-1.96 (28.60%)

-2.75 (49.41%)

-5.43 (23.12%)

Asset Turnover

0.75 (46.02%)

0.52 (-6.53%)

0.55 (-26.44%)

0.75 (150.50%)

Current Ratio

1.7 (-49.63%)

3.37 (-36.63%)

5.31 (42.10%)

3.74 (-18.59%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$127,628,000 (-37.64%)

-$92,723,000 (38.05%)

-$149,672,000 (-39.45%)

-$107,328,000 (33.08%)

Enterprise Value (EV)

$205,843,200 (-11.30%)

$232,055,902 (-39.32%)

$382,397,088 (-27.33%)

$526,221,412 (-55.58%)

Earnings Before Tax (EBT)

-$76,365,000 (46.51%)

-$142,776,000 (13.43%)

-$164,922,000 (-33.19%)

-$123,820,000 (36.81%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$38,603,000 (67.40%)

-$118,423,000 (14.99%)

-$139,305,000 (-43.64%)

-$96,985,000 (42.22%)

Invested Capital

$203,864,000 (-30.84%)

$294,783,000 (-11.86%)

$334,453,000 (55.76%)

$214,720,000 (-27.18%)

Working Capital

$64,228,000 (-60.94%)

$164,442,000 (-42.15%)

$284,254,000 (40.80%)

$201,888,000 (-6.68%)

Tangible Asset Value

$164,418,000 (-31.62%)

$240,438,000 (-32.87%)

$358,172,000 (17.32%)

$305,305,000 (-2.47%)

Market Capitalization

$84,750,200 (-14.46%)

$99,071,902 (-64.09%)

$275,927,088 (-43.20%)

$485,770,412 (-57.36%)

Average Equity

-$161,689,750 (-83.21%)

-$88,256,000 (0.93%)

-$89,088,250 (-8.50%)

-$82,105,500 (-176.33%)

Average Assets

$193,082,250 (-31.90%)

$283,507,000 (-0.52%)

$284,979,750 (1.70%)

$280,218,750 (-22.53%)

Invested Capital Average

$250,995,250 (-24.40%)

$332,019,750 (15.16%)

$288,308,000 (13.99%)

$252,914,250 (-20.05%)

Shares

125,314,506 (9.41%)

114,533,991 (41.13%)

81,155,026 (7.42%)

75,547,498 (2.64%)